Abstract A53: Hypermethylated RASSF1A as circulating tumor marker in pediatric and adolescent solid tumors
Lieke M. J. van Zogchel(Sanquin), Godelieve A.M. Tytgat(Emma Kinderziekenhuis), Janine Stutterheim(Princess Máxima Center), Esther M. van Wezel(Sanquin), C. Ellen van der Schoot(Sanquin), Nathalie S.M. Lak(University Medical Center Utrecht), Jalenka van Wijk(Sanquin), João Lobo(Universidade do Porto), Lily Zappeij‐Kannegieter(Sanquin), Leendert H. J. Looijenga(University Medical Center Utrecht)
Cited by 1
Related Papers
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
Intragenic ERBB2 kinase mutations in tumours
|Nature|2004|790
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
|Nature Genetics|2015|563
New gene functions in megakaryopoiesis and platelet formation
|Nature|2011|424